Inspired by cancer immunotherapy, Alzheimer's researchers have engineered mouse astrocyte brain cells to recognize amyloid-β and clear cellular debris. The approach, delivered via intravenous injection, reduced plaques by half in older mice with established disease, and prevented it in young mice.
